143 related articles for article (PubMed ID: 28425573)
1. Evaluation of Australian dermatological postoperative patient information leaflets: Should we have a national checklist?
Hunt WT; O'Sullivan NA; Donnelly A
Australas J Dermatol; 2018 May; 59(2):118-123. PubMed ID: 28425573
[TBL] [Abstract][Full Text] [Related]
2. Dermatological postoperative patient information leaflets: is it time for more uniformity?
Hunt WT; McGrath EJ
Clin Exp Dermatol; 2015 Oct; 40(7):747-52. PubMed ID: 26271961
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Readability of Dermatological Postoperative Patient Information Leaflets Across England.
Hunt WT; McGrath EJ
Dermatol Surg; 2016 Jun; 42(6):757-63. PubMed ID: 27176870
[TBL] [Abstract][Full Text] [Related]
4. Patient information leaflets for antidepressants: are patients getting the information they need?
Haw C; Stubbs J
J Affect Disord; 2011 Jan; 128(1-2):165-70. PubMed ID: 20656359
[TBL] [Abstract][Full Text] [Related]
5. Variability in Wound Care Recommendations Following Dermatologic Procedures.
Nguyen JK; Huang A; Siegel DM; Jagdeo J
Dermatol Surg; 2020 Feb; 46(2):186-191. PubMed ID: 30939523
[TBL] [Abstract][Full Text] [Related]
6. Analysis of patient information leaflets provided by a district general hospital by the Flesch and Flesch-Kincaid method.
Williamson JM; Martin AG
Int J Clin Pract; 2010 Dec; 64(13):1824-31. PubMed ID: 21070533
[TBL] [Abstract][Full Text] [Related]
7. The development of patient information leaflets incorporating patient diversity considerations: Varicocele embolisation and fluoroscopy guided joint injection examinations.
Vassallo T; Mizzi A; Depasquale R; Maher M; Rainford L
Radiography (Lond); 2018 Oct; 24 Suppl 1():S20-S27. PubMed ID: 30166004
[TBL] [Abstract][Full Text] [Related]
8. Patient information leaflets (PILs) for UK randomised controlled trials: a feasibility study exploring whether they contain information to support decision making about trial participation.
Gillies K; Huang W; Skea Z; Brehaut J; Cotton S
Trials; 2014 Feb; 15():62. PubMed ID: 24548781
[TBL] [Abstract][Full Text] [Related]
9. Artificial intelligence-generated patient information leaflets: a comparison of contents according to British Association of Dermatologists standards.
Verran C
Clin Exp Dermatol; 2024 Jun; 49(7):711-714. PubMed ID: 38169318
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of instructions in patient information leaflets for the use of intranasal corticosteroid sprays: an observational study.
Rollema C; van Roon EM; Schilder AG; de Vries TW
BMJ Open; 2019 Jan; 9(1):e026710. PubMed ID: 30647049
[TBL] [Abstract][Full Text] [Related]
11. Retention strategies are routinely communicated to potential trial participants but often differ from what was planned in the trial protocol: an analysis of adult participant information leaflets and their corresponding protocols.
Murphy E; Gillies K; Shiely F
Trials; 2024 Jun; 25(1):372. PubMed ID: 38858790
[TBL] [Abstract][Full Text] [Related]
12. Patient information leaflets--helpful guidance or a source of confusion?
Bjerrum L; Foged A
Pharmacoepidemiol Drug Saf; 2003; 12(1):55-9. PubMed ID: 12616848
[TBL] [Abstract][Full Text] [Related]
13. When describing harms and benefits to potential trial participants, participant information leaflets are inadequate.
Cuddihy L; Howick J; Murphy E; Shiely F
Trials; 2024 May; 25(1):292. PubMed ID: 38693579
[TBL] [Abstract][Full Text] [Related]
14. Patient information leaflets for placebo-controlled surgical trials: a review of current practice and recommendations for developers.
Cousins S; Huttman M; Blencowe N; Tsang C; Elliott D; Blazeby J; Beard DJ; Campbell MK; Gillies K
Trials; 2024 May; 25(1):339. PubMed ID: 38778336
[TBL] [Abstract][Full Text] [Related]
15. Analysis of the data on pregnancy and lactation provided by patient information leaflets of anti-rheumatic drugs in Argentina.
Sabando MO; Saavedra MA; Sequeira G; Kerzberg E
Rheumatol Int; 2018 Apr; 38(4):669-673. PubMed ID: 29332199
[TBL] [Abstract][Full Text] [Related]
16. Readability and content of patient information leaflets for endoscopic procedures.
Gargoum FS; O'Keeffe ST
Ir J Med Sci; 2014 Sep; 183(3):429-32. PubMed ID: 24174395
[TBL] [Abstract][Full Text] [Related]
17. Using alternative methodologies for evaluating patient medication leaflets.
Krass I; Svarstad BL; Bultman D
Patient Educ Couns; 2002 May; 47(1):29-35. PubMed ID: 12023098
[TBL] [Abstract][Full Text] [Related]
18. Consumer medication information in the United States, Europe, and Australia: a comparative evaluation.
Raynor DK; Svarstad B; Knapp P; Aslani P; Rogers MB; Koo M; Krass I; Silcock J
J Am Pharm Assoc (2003); 2007; 47(6):717-24. PubMed ID: 18032134
[TBL] [Abstract][Full Text] [Related]
19. How (not) to inform patients about drug use: use and effects of negations in Dutch patient information leaflets.
Burgers C; Beukeboom CJ; Sparks L; Diepeveen V
Pharmacoepidemiol Drug Saf; 2015 Feb; 24(2):137-43. PubMed ID: 25044310
[TBL] [Abstract][Full Text] [Related]
20. A Critical Analysis of the Exercise Prescription and Return to Activity Advice That Is Provided in Patient Information Leaflets Following Lumbar Spine Surgery.
Low M; Burgess LC; Wainwright TW
Medicina (Kaunas); 2019 Jul; 55(7):. PubMed ID: 31284666
[No Abstract] [Full Text] [Related]
[Next] [New Search]
